Suven Pharmaceuticals Faces Decline Amid Broader Market Challenges and Mixed Momentum Signals

Suven Pharmaceuticals has experienced a notable decline of 3.36% on April 1, 2025, underperforming its sector by 2.29%. The stock reached an intraday low of Rs 1105, reflecting a drop of 3.96%. Despite this downturn, Suven Pharmaceuticals remains above its 200-day moving average, although it is currently trading below its 5-day, 20-day, 50-day, and 100-day moving averages.
In the broader market context, the Sensex has also faced significant challenges, falling sharply by 680 points to 76,202.58, a decline of 1.57%. While the Sensex is trading above its 50-day moving average, this average is below the 200-day moving average, indicating mixed signals in market momentum.

Over various time frames, Suven Pharmaceuticals has shown contrasting performance. In the past month, the stock has decreased by 8.55%, while it has gained 66.41% over the past year. Year-to-date, it has declined by 1.57%, but over three years, it has appreciated by 84.46%, and over five years, it has surged by an impressive 935.36%.